I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Daenthanasanmak, Anusara
40
results:
Search for persons
X
Format
Online (40)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (26)
Sorted by: Year
Sorted by: Relevance
?
1
Triple combination of BET plus PI3K and NF-κB inhibitors ex..:
Daenthanasanmak, Anusara
;
Bamford, Richard N.
;
Yoshioka, Makoto
...
Blood Advances. 6 (2022) 7 - p. 2346-2360 , 2022
Link:
https://doi.org/10.1182/..
?
2
A very long-acting IL-15: implications for the immunotherap..:
Hangasky, John A
;
Chen, Wei
;
Dubois, Sigrid P
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 1 - p. e004104 , 2022
Link:
https://doi.org/10.1136/..
?
3
Genome-wide CRISPR screen identifies CDK6 as a therapeutic ..:
Ishio, Takashi
;
Kumar, Sarvesh
;
Shimono, Joji
...
Blood. 139 (2022) 10 - p. 1541-1556 , 2022
Link:
https://doi.org/10.1182/..
?
4
Triple combination of BET plus PI3K and NF-κB inhibitors ex..:
Daenthanasanmak, Anusara
;
Bamford, Richard N
;
Yoshioka, Makoto
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006306/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
5
Genome-wide CRISPR screen identifies CDK6 as a therapeutic ..:
Ishio, Takashi
;
Kumar, Sarvesh
;
Shimono, Joji
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914179/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
6
A very long-acting IL-15: implications for the immunotherap..:
Wei Chen
;
Thomas A Waldmann
;
Anusara Daenthanasanmak
...
https://jitc.bmj.com/content/10/1/e004104.full. , 2022
Link:
https://doi.org/10.1136/..
?
7
A very long-acting IL-15: implications for the immunotherap..:
Hangasky, John A
;
Chen, Wei
;
Dubois, Sigrid P
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804710/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targetin..:
Daenthanasanmak, Anusara
;
Lin, Yuquan
;
Zhang, Meili
...
Translational Oncology. 14 (2021) 1 - p. 100913 , 2021
Link:
https://doi.org/10.1016/..
?
9
EGR1 addiction in diffuse large B cell lymphoma:
Kimpara, Shuichi
;
Lu, Li
;
Hoang, Nguyet M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349889/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
10
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targetin..:
Anusara Daenthanasanmak
;
Yuquan Lin
;
Meili Zhang
...
http://www.sciencedirect.com/science/article/pii/S1936523320304058. , 2021
Link:
https://doi.org/10.1016/..
?
11
Targeting the Complement Alternative Pathway Permits Graft ..:
Nguyen, Hung D
;
Alawieh, Ali
;
Bastian, David
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334060/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
12
Vitamin C stabilizes CD8+ iTregs and enhances their therape..:
Iamsawat, Supinya
;
Tian, Linlu
;
Daenthanasanmak, Anusara
...
Blood Advances. 3 (2019) 24 - p. 4187-4201 , 2019
Link:
https://doi.org/10.1182/..
?
13
Vitamin C stabilizes CD8(+) iTregs and enhances their thera..:
Iamsawat, Supinya
;
Tian, Linlu
;
Daenthanasanmak, Anusara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929397/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
14
Thioredoxin-1 confines T cell alloresponse and pathogenicit..:
Sofi, M. Hanief
;
Wu, Yongxia
;
Schutt, Steven D
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597211/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
15
Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-re..:
Daenthanasanmak, Anusara
;
Iamsawat, Supinya
;
Chakraborty, Paramita
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337874/. , 2019
Link:
http://www.ncbi.nlm.nih...
1-15